Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.23 Million SEK | 285.18% |
| 2022 | -5.52 Million SEK | 56.24% |
| 2021 | -12.62 Million SEK | -212.19% |
| 2020 | -4.04 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.22 Million SEK | 6.91% |
| 2024 Q1 | 3.94 Million SEK | -61.41% |
| 2023 Q3 | 3.46 Million SEK | 206.68% |
| 2023 FY | 10.23 Million SEK | 285.18% |
| 2023 Q1 | -7.17 Million SEK | -29.79% |
| 2023 Q2 | -3.24 Million SEK | 54.71% |
| 2023 Q4 | 10.23 Million SEK | 195.27% |
| 2022 Q3 | -8.25 Million SEK | 47.78% |
| 2022 Q4 | -5.52 Million SEK | 33.05% |
| 2022 FY | -5.52 Million SEK | 56.24% |
| 2022 Q2 | -15.8 Million SEK | -112.31% |
| 2022 Q1 | -7.44 Million SEK | 41.05% |
| 2021 Q1 | -3.69 Million SEK | 0.0% |
| 2021 FY | -12.62 Million SEK | -212.19% |
| 2021 Q2 | -20.94 Million SEK | -467.48% |
| 2021 Q4 | -12.62 Million SEK | 26.15% |
| 2021 Q3 | -17.09 Million SEK | 18.36% |
| 2020 FY | -4.04 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | 129.108% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 99.166% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 99.166% |
| Arcoma AB | -1.12 Million SEK | 1007.004% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 90.689% |
| BICO Group AB (publ) | 927.9 Million SEK | 98.897% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 92.057% |
| CellaVision AB (publ) | -56.94 Million SEK | 117.967% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | 168.771% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | 221.002% |
| C-Rad AB (publ) | -127.6 Million SEK | 108.018% |
| Dignitana AB (publ) | 13.07 Million SEK | 21.763% |
| Episurf Medical AB (publ) | -52.7 Million SEK | 119.414% |
| Getinge AB (publ) | 5.4 Billion SEK | 99.811% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | 129.187% |
| Iconovo AB (publ) | -10.75 Million SEK | 195.125% |
| Integrum AB (publ) | -10.47 Million SEK | 197.656% |
| Luxbright AB (publ) | -13.83 Million SEK | 173.958% |
| Mentice AB (publ) | -49.56 Million SEK | 120.642% |
| OssDsign AB (publ) | -162.78 Million SEK | 106.285% |
| Paxman AB (publ) | -11.41 Million SEK | 189.659% |
| Promimic AB (publ) | -50.32 Million SEK | 120.331% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 46.35% |
| SciBase Holding AB (publ) | -27.32 Million SEK | 137.443% |
| ScandiDos AB (publ) | -1.53 Million SEK | 768.256% |
| Sectra AB (publ) | -772.85 Million SEK | 101.324% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 104.51% |
| Senzime AB (publ) | -139.54 Million SEK | 107.332% |
| SpectraCure AB (publ) | -50.23 Million SEK | 120.367% |
| Stille AB | -178.5 Million SEK | 105.732% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 99.167% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 104.766% |